Future Pharmacology MDPI

Future Pharmacology is an international, peer-reviewed, #openaccess journal on #pharmacology, #drugdiscovery, and #therapeutics published quarterly by MDPI

[Future Pharmacology MDPI @FuturePharmMDPI]

Meet our team at CRS Annual Meeting in Lisbon!

📍 Booth #21
📆 6-9 July 2026
📌 Lisbon Congress Centre, Lisbon

[Pharmaceutics MDPI @MDPIpharma]

🚀 Join us at the 2026 @CRSScience Annual Meeting & Exposition for inspiring discussions on the latest research, projects, and innovations in the field!

🔍 Be sure to visit MDPI Booth #21 and connect with us!

We look forward to meeting you!

#CRS2026 #PharmaceuticsMDPI

[Future Pharmacology MDPI @FuturePharmMDPI]

🚀 New Paper Alert!

📄 Using 5-Nitroimidazole Derivatives against Neglected Tropical Protozoan Diseases: Systematic Review 💊
👨‍🔬 Vichi-Ramírez et al.

Read more at: https://t.co/ybQ7f3lCjV

[Future Pharmacology MDPI @FuturePharmMDPI]

New Section Announcement 🔬

Future Pharmacology is pleased to introduce a new journal section: 🧬 Molecular, Cellular and Biochemical Pharmacology 🧪

[🔗] https://t.co/W0kaGmODV4

📌 Discover the scope and submit your work today!

[MDPI @MDPIOpenAccess]

Back matter serves to supplement the main body of text and demonstrate how your research meets the highest ethical standards.

Understanding its core components is essential for upholding research integrity.

Learn more: https://t.co/LKECzXTGEW

[Future Pharmacology MDPI @FuturePharmMDPI]

📢 Deadline Extended!

The Special Issue “Novel Therapeutic Agents and Innovative Treatment Strategies Against Infectious Diseases” has been extended until 20 January 2027! 💊

🔬 Guest Editor: Dr. Sara Consalvi

🔗 https://t.co/LJSbIScSJ1

[MDPI @MDPIOpenAccess]

2026 marks 30 years of MDPI and coincides with milestone anniversaries for 19 of its international, Open Access, peer-reviewed journals.

Learn more: https://t.co/X2BwTPfV2o

[MDPI @MDPIOpenAccess]

The 2025 citation metrics have been officially released in the Journal Citation Reports (JCR).

330 MDPI journals earned a Journal Impact Factor (JIF). Of them, 29 journals received their first JIF and 254 increased theirs.

Learn more: https://t.co/casSQiv0tE

[Future Pharmacology MDPI @FuturePharmMDPI]

📢 Deadline Extended!

The Special Issue “Drugs, Growth Factors and Active Molecules for Tissue Engineering and Regenerative Medicine” has been extended until 30 November 2026! 💊

🔬 Guest Editor: Dr. Natasha Maurmann

🔗 https://t.co/vr5qbF3Sin

[Future Pharmacology MDPI @FuturePharmMDPI]

We are thrilled to be part of the @CRSScience 2026 Annual Meeting & Exposition and our delegates are eager to meet you in person.

📆 6–9 July 2026
📌 Lisbon, Portugal

For additional details about the conference, please click on the following link: https://t.co/sngcBkH88M

[Future Pharmacology MDPI @FuturePharmMDPI]

🚀 New Paper Alert!

📄 Modulation of Staphylococcus aureus Biofilm Formation through Subinhibitory Concentrations of Biogenic Silver Nanoparticles and Simvastatin 💊
👨‍🔬 da SIlva et al.

Read more at: https://t.co/KcqoD2CnlL

[Future Pharmacology MDPI @FuturePharmMDPI]

🚀 New Paper Alert!

📄 The Role of Lysophosphatidic Acid in Neuropsychiatric and Neurodegenerative Disorders 💊
👨‍🔬 Dedoni et al.

Read more at: https://t.co/ozvyuflW4Q

[Future Pharmacology MDPI @FuturePharmMDPI]

🚀 New Paper Alert!

📄 Physiologically Based Pharmacokinetic Modelling of UGT Substrate Drugs Lamotrigine and Raltegravir during Pregnancy 💊
👨‍🔬 Berezowska et al.

Read more at: https://t.co/caqJXLPtel

[MDPI @MDPIOpenAccess]

Editing services offer many benefits to authors, such as ensuring accuracy in language and grammar, enhancing structure and improving readability.

Learn more about how MDPI’s Author Services can support you: https://t.co/b5wzdIClhl

[Future Pharmacology MDPI @FuturePharmMDPI]

🚀 Highly Cited Paper Alert!

📄 Physiologically Based Pharmacokinetic Modelling of UGT Substrate Drugs Lamotrigine and Raltegravir during Pregnancy 💊
👨‍🔬 Berezowska et al.

Read more at: https://t.co/X29eaa7rFe

[Future Pharmacology MDPI @FuturePharmMDPI]

🚀 Highly Cited Paper Alert!

📄 Pseudomonas aeruginosa: A Bacterial Platform for Biopharmaceutical Production 💊
👨‍🔬 Camilios-Neto et al.

Read more at: https://t.co/WwW29Dh2x3

[Future Pharmacology MDPI @FuturePharmMDPI]

📢 We have launched 4 new Sections to support cutting-edge pharmacology research!

•Molecular, Cellular & Biochemical Pharmacology
•Drug Discovery & Preclinical Research
Pharmacokinetics, Metabolism & Toxicology
Clinical & Translational Pharmacology

🔗 https://t.co/fufxArl9fN

[Future Pharmacology MDPI @FuturePharmMDPI]

✨Scholar Visiting ✨
Nebojsa Salaj, was pleased to visit Dr. Mirko Manchia, Editorial Board Member of Future Pharmacology, at the San Giovanni di Dio Hospital in Cagliari. 🎉

They exchanged perspectives on OA, publishing initiatives and future collaboration opportunities. 💡

[MDPI @MDPIOpenAccess]

With more than 30 years in open access publishing, MDPI uses its experience to help societies willing to venture into this publication model.

Doing so supports scholarly communities and broadens the reach of open access.

Learn more: https://t.co/WHgvBdPjFx

#MDPI30

[MDPI @MDPIOpenAccess]

Singapore has a robust university infrastructure. Several of the country’s leading funding agencies also require publications be made Open Access within 12 months.

Learn more about Open Access in Singapore: https://t.co/brDOGyuN58

[Future Pharmacology MDPI @FuturePharmMDPI]

🚀 Highly Cited Paper Alert!

📄 Preclinical Pharmacology of the Low-Impact Ampakine CX717 💊
👨‍🔬 Radin et al.

Read more at: https://t.co/X3ftSMKhg1